Hocoma logo

Hocoma

Hocoma makes the Lokomat robotic gait trainer and other robotic and sensor-based devices for movement therapy. It is in a Swiss court-supervised restructuring, with a definitive debt moratorium from October 9, 2026, to April 9, 2027, and it has ceased sales in the United States. Its parent DIH reported $62.9 million in fiscal 2025 revenue.1,3,2,4

Robotics Reviewed Editorial TeamUpdated November 9, 2026dih.com

Our take

The Lokomat is the most studied robotic gait trainer, and many rehab centers already run one. The company behind it is now in a court-supervised restructuring.1,3

Buyers should treat service and spare parts as the main risk. Hocoma has stopped US sales and routes North American support through a separate address.2

Scores by criterion

Hocoma scores out of 10
Pricing transparency4.0
Product maturity9.0
Deployment evidence8.5
Company durability2.0
Ease of integration5.5
Overall score (average of the five)5.8

Each criterion is defined on our methodology page.

Who uses Hocoma and what it's for

Rehabilitation centers that already run Lokomat systems and need to plan service and upgrades.2,4

Clinics outside the US considering Hocoma devices during the restructuring.2,3

History

Hocoma AG was registered in 1996 in Volketswil near Zurich and is a brand of DIH, which also owns Motek.3,1

DIH reported $62.9 million in revenue for the fiscal year ended March 31, 2025, with the Lokomat accounting for more than 45%, and its auditor raised substantial doubt about its ability to continue as a going concern.4

Restructuring

A provisional debt moratorium was granted on February 10, 2026. On October 9, 2026, the Uster district court granted a definitive six-month moratorium to April 9, 2027, with Transliq AG as administrator, and creditors must file claims by November 30, 2026.3

Hocoma's US site says it has ceased sales activities in the United States and lists separate contacts for device maintenance and patient incident reports.2

Pricing

A 2023 cost study reported that a Slovak rehab center paid EUR321,160 for a Lokomat in 2007 and that the newest Lokomat Pro FreeD Kombi cost EUR881,292 in 2022.5

Annual service, safety inspections and spare parts were billed as a flat yearly fee in that study.5

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprises45678910Review Score← Smaller operationsLarge enterprises →Who it's built for5.86.15.96.66.3
Hocoma and its competitors
CompanyProductPricing modelDeployment footprintWhere Hocoma wins or loses
HocomaLokomat robotic gait trainer and movement therapy devices1Lokomat Pro FreeD Kombi about EUR881,292 in 20225Definitive debt moratorium to April 9, 20273Most-studied gait robot, maker in restructuring
TyromotionLexo end-effector gait trainer plus hand, arm and balance devices7About EUR150,000 average per device (2017)9EUR15.56M revenue in FY to March 20258Tyromotion wins on stability and fast setup. Hocoma wins on Lokomat evidence.
WandercraftAtalante X and Eve self-balancing exoskeletons18Not published18Devices in more than 700 rehabilitation centers after buying Ekso19Wandercraft wins on overground walking and funding. Hocoma wins on installed base.
CyberdyneMedical HAL wearable robot driven by the wearer's bioelectric signals13Not published; mainly rentals and treatment services14Approvals or certifications in more than 20 countries20Cyberdyne wins on stability and HAL control. Hocoma wins on treadmill-based evidence.
LifewardReWalk personal exoskeleton and AlterG anti-gravity systems17Medicare fee of $91,032 for a personal exoskeleton16Individual users through Medicare and insurers; AlterG in more than 4,000 facilities16Lifeward wins on personal exoskeletons. Hocoma wins on clinic gait volume.

Limits

Hocoma is in a court-supervised debt moratorium until April 9, 2027.3

It has ceased US sales.2

Its parent's auditor raised going-concern doubt.4

What customers say

Where it helps

Existing Lokomat owners outside the US can keep using installed systems while confirming service terms with the administrator.3,2

Research centers that need Lokomat comparability with published studies remain the main fit.5

Where it falls short

New buyers wanting a stable gait robot supplier should look at Tyromotion, Wandercraft or Cyberdyne.

Leadership

    Sources

    1. DIH, Hocoma, accessed November 9, 2026
    2. Hocoma, US site notice, archived January 22, 2026, accessed November 9, 2026
    3. Moneyhouse, Hocoma AG commercial register and SHAB notices, accessed November 9, 2026
    4. DIH Holding US, Form 10-K for fiscal year ended March 31, 2025, accessed November 9, 2026
    5. Cost Effectiveness and Resource Allocation, Cost-effectiveness of robot-assisted gait training in cerebral palsy, 2023, accessed November 9, 2026
    6. Tyromotion, Team, accessed November 9, 2026
    7. Tyromotion, Lexo gait trainer, accessed November 9, 2026
    8. Researchly, Tyromotion GmbH, accessed November 9, 2026
    9. Die Gründer, Tyromotion founders, sale process and new CEO, November 2026, accessed November 9, 2026
    10. Wandercraft, Atalante X, accessed November 1, 2026
    11. Wandercraft, Eve personal exoskeleton, accessed November 1, 2026
    12. Wandercraft, Wandercraft acquires Ekso Bionics, accessed November 1, 2026
    13. Cyberdyne, Medical HAL lower limb type, accessed November 2, 2026
    14. Cyberdyne, Financial results briefing for the fiscal year ended March 31, 2026, May 14, 2026, accessed November 3, 2026
    15. Cyberdyne, Consolidated financial results for the fiscal year ended March 31, 2026, May 14, 2026, accessed November 3, 2026
    16. Lifeward, Form 10-Q for the quarter ended September 30, 2024, accessed November 1, 2026
    17. Lifeward, Fourth quarter and full year 2025 financial results, accessed November 1, 2026
    18. Wandercraft, Homepage, accessed November 2, 2026
    19. IZON, Wandercraft acquires Ekso Bionics to form major exoskeleton player, accessed November 2, 2026
    20. Cyberdyne, About Cyberdyne, accessed November 3, 2026